Fate Therapeutics Inc. buy Wedbush
Start price
27.10.25
/
50%
€1.35
Target price
27.10.26
€6.02
Performance (%)
-22.75%
Price
02.02.26
€1.04
Summary
This prediction is currently active. The price of Fate Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -22.75%. This prediction currently runs until 27.10.26. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Fate Therapeutics Inc. | -0.048% | -0.048% |
| iShares Core DAX® | -0.436% | 1.181% |
| iShares Nasdaq 100 | 0.854% | 1.475% |
| iShares Nikkei 225® | 2.652% | 6.401% |
| iShares S&P 500 | 1.190% | 1.169% |
Comments by Wedbush for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics (NASDAQ:FATE) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $7.00 price target on the stock, up previously from $5.00.
Ratings data for FATE provided by MarketBeat